Mirum Pharmaceuticals Inc. (MIRM) is a biopharmaceutical company that focuses on the development and commercialization of novel therapies for debilitating liver diseases.
More from Stocks
Let's look at the names I'm eyeing, including my pick of the week.
Homebuilders and owners of commercial real estate in particular are feeling the rate-induced pain, and it likely will intensify in the months ahead.
I'm the most bullish I have been on risk and rates since earlier this year when we were looking for a short squeeze.
The market is struggling with a downtrend, and an oversold bounce is likely, but whether it will turn into a new uptrend is the key question.
Something's been nagging me about sentiment, so I went to Twitter to get to the bottom of it. Plus, what to expect from the Russell this week and a look at the S&P's head-and-shoulders top.